PubMed HealthSearch

PubMed · 4273935

Decrease of muscle rigidity by dimethylaminoadamantan (DMMA) in intercollicularly decerebrated cats.

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K H Sontag, P Wand. 1973. Decrease of muscle rigidity by dimethylaminoadamantan (DMMA) in intercollicularly decerebrated cats.. https://pubmed.ncbi.nlm.nih.gov/4273935/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

A double-blind, placebo-controlled trial of amantadine for the treatment of fatigue in patients with the post-polio syndrome.

Because amantadine has been shown to reduce fatigue in patients with multiple sclerosis, we performed a double-blind, placebo-controlled study to assess its efficacy in the disabling symptom of post-polio fatigue. Twenty-three patients completed six weeks of therapy. Fatigue was measured by the patients using visual analogue scales (twice per day) and numerical fatigue severity scales (once per week) and by overall impression (at end of therapy). Formal neuropsychological testing and serum drug levels were performed to assess compliance. On all measures, no significant difference was found between treatment and placebo groups. Fifty-four percent of patients given amantadine and 43% given placebo reported a decrease in fatigue; however, the visual analogue scales and fatigue severity scales failed to reflect any improvement. Several patients in the treatment group elected to continue amantadine therapy after the study was completed. Our findings suggest that amantadine is not significantly better than placebo in reducing the sensation of fatigue in post-polio syndrome, and that the measures we employed were insensitive to capture the subjective response experienced by a few patients.

Amantadine

Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.

These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (superseding MMWR 1994;43(No. RR-9) 1-13 and MMWR 1994;43(No. RR-15): 1-10). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1995-96, b) side effects and adverse reactions, and c) the vaccination of pregnant women.

Amantadine

Amantadine stimulates sexual behavior in male rats.

The effects of amantadine on sexual behavior, penile erection, and seminal emission of male rats was studied. Amantadine significantly decreased latency of mounts in all doses (1.25 to 50 mg/kg), and decreased the number of mounts and intromission latency at the highest doses used. The lowest dose of amantadine significantly increased ejaculation latency and intromission frequency, while higher doses significantly reduced it, which indicates a biphasic response of the drug. Additionally, seminal emission, erections, and genital grooming were significantly induced by amantadine. Amantadine-induced seminal emissions were impaired by spinal cord transection, which suggests the involvement of supraspinal structures in the drug action. Haloperidol and atropine sulphate significantly reduced seminal emissions and penile erections induced by amantadine. These results demonstrate that amantadine stimulates sexual behavior and genital reflexes in male rats and suggest a facilitatory effect of the drug that probably involves different mechanisms of action.

Amantadine